$CNMD
CONMED Corp

2015 Q4 Form 10-Q Financial Statement

#000081695615000010 Filed on October 23, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $191.0M $169.2M $175.0M
YoY Change -2.04% -3.3% -2.4%
Cost Of Revenue $85.80M $75.64M $78.55M
YoY Change -3.7% -3.7% -6.3%
Gross Profit $102.4M $93.55M $96.41M
YoY Change -1.59% -2.97% 1.04%
Gross Profit Margin 53.6% 55.29% 55.11%
Selling, General & Admin $76.30M $72.06M $87.06M
YoY Change -0.13% -17.23% 18.48%
% of Gross Profit 74.53% 77.03% 90.29%
Research & Development $6.700M $6.652M $6.910M
YoY Change -5.63% -3.73% -2.79%
% of Gross Profit 6.54% 7.11% 7.17%
Depreciation & Amortization $11.60M $11.20M $11.70M
YoY Change -0.85% -4.27% 0.0%
% of Gross Profit 11.33% 11.97% 12.14%
Operating Expenses $83.10M $78.71M $93.97M
YoY Change 12.3% -16.24% 8.48%
Operating Profit $19.28M $14.84M $2.449M
YoY Change -35.82% 505.88% -72.19%
Interest Expense -$1.600M $1.504M $1.540M
YoY Change 6.67% -2.34% 11.43%
% of Operating Profit -8.3% 10.14% 62.88%
Other Income/Expense, Net
YoY Change
Pretax Income $11.40M $13.33M $909.0K
YoY Change -26.92% 1366.89% -87.75%
Income Tax $3.500M $4.461M -$1.063M
% Of Pretax Income 30.7% 33.46% -116.94%
Net Earnings $7.852M $8.873M $1.972M
YoY Change -30.75% 349.95% -65.32%
Net Earnings / Revenue 4.11% 5.24% 1.13%
Basic Earnings Per Share $0.28 $0.32 $0.07
Diluted Earnings Per Share $0.28 $0.32 $0.07
COMMON SHARES
Basic Shares Outstanding 27.70M shares 27.70M shares 27.45M shares
Diluted Shares Outstanding 27.90M shares 27.69M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $72.50M $65.30M $64.60M
YoY Change 9.35% 1.08% 29.72%
Cash & Equivalents $72.50M $65.33M $64.61M
Short-Term Investments
Other Short-Term Assets $20.10M $32.10M $30.50M
YoY Change -45.38% 5.25% 4.81%
Inventory $133.4M $161.6M $162.1M
Prepaid Expenses
Receivables $133.9M $124.7M $123.3M
Other Receivables $0.00 $0.00 $4.900M
Total Short-Term Assets $359.8M $383.7M $385.4M
YoY Change -5.6% -0.44% 5.9%
LONG-TERM ASSETS
Property, Plant & Equipment $125.5M $130.7M $135.8M
YoY Change -5.98% -3.76% -1.93%
Goodwill $260.7M $260.8M $256.2M
YoY Change 1.72% 1.77% 3.1%
Intangibles $308.2M $308.1M $319.2M
YoY Change -2.61% -3.48% -1.09%
Long-Term Investments
YoY Change
Other Assets $47.60M $10.80M $12.90M
YoY Change 336.7% -16.28% 25.24%
Total Long-Term Assets $741.9M $710.4M $724.1M
YoY Change 3.47% -1.9% 0.57%
TOTAL ASSETS
Total Short-Term Assets $359.8M $383.7M $385.4M
Total Long-Term Assets $741.9M $710.4M $724.1M
Total Assets $1.102B $1.094B $1.110B
YoY Change 0.32% -1.39% 2.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.72M $31.59M $31.06M
YoY Change 46.18% 1.71% 14.03%
Accrued Expenses $31.80M $28.80M $30.70M
YoY Change -12.64% -6.19% 17.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.339M $1.285M $1.187M
YoY Change 8.51% 8.26% 8.6%
Total Short-Term Liabilities $119.7M $111.7M $121.8M
YoY Change 3.24% -8.29% 20.69%
LONG-TERM LIABILITIES
Long-Term Debt $269.5M $260.5M $246.8M
YoY Change 12.19% 5.56% 10.18%
Other Long-Term Liabilities $24.06M $29.02M $32.69M
YoY Change -50.41% -11.22% -45.16%
Total Long-Term Liabilities $293.5M $289.6M $279.5M
YoY Change 1.67% 3.59% -1.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $119.7M $111.7M $121.8M
Total Long-Term Liabilities $293.5M $289.6M $279.5M
Total Liabilities $516.6M $516.6M $516.8M
YoY Change -0.05% -0.03% 5.11%
SHAREHOLDERS EQUITY
Retained Earnings $414.5M $412.2M $400.3M
YoY Change 2.06% 2.97% 2.34%
Common Stock $313.0K $313.0K $313.0K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $100.8M $101.0M $106.1M
YoY Change -4.11% -4.8% 9.69%
Treasury Stock Shares 3.590M shares
Shareholders Equity $585.1M $577.4M $592.7M
YoY Change
Total Liabilities & Shareholders Equity $1.102B $1.094B $1.110B
YoY Change 0.32% -1.39% 2.36%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $7.852M $8.873M $1.972M
YoY Change -30.75% 349.95% -65.32%
Depreciation, Depletion And Amortization $11.60M $11.20M $11.70M
YoY Change -0.85% -4.27% 0.0%
Cash From Operating Activities $9.400M $13.60M $14.60M
YoY Change -63.42% -6.85% -51.97%
INVESTING ACTIVITIES
Capital Expenditures -$3.500M -$3.700M -$3.700M
YoY Change 12.9% 0.0% -31.48%
Acquisitions
YoY Change
Other Investing Activities -$3.300M $0.00 -$1.200M
YoY Change -19.51% -100.0%
Cash From Investing Activities -$6.800M -$3.700M -$4.900M
YoY Change -5.56% -24.49% -9.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.500M -4.200M -1.300M
YoY Change -139.86% 223.08% -91.1%
NET CHANGE
Cash From Operating Activities 9.400M 13.60M 14.60M
Cash From Investing Activities -6.800M -3.700M -4.900M
Cash From Financing Activities 5.500M -4.200M -1.300M
Net Change In Cash 8.100M 5.700M 8.400M
YoY Change 72.34% -32.14% -19.23%
FREE CASH FLOW
Cash From Operating Activities $9.400M $13.60M $14.60M
Capital Expenditures -$3.500M -$3.700M -$3.700M
Free Cash Flow $12.90M $17.30M $18.30M
YoY Change -55.21% -5.46% -48.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Amount
JointDevelopmentAndDistributionAgreementConditionalPaymentAmount
84000000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Period
JointDevelopmentAndDistributionAgreementConditionalPaymentPeriod
P4Y
CY2012Q1 cnmd Joint Development And Distribution Agreement Up Front Payment
JointDevelopmentAndDistributionAgreementUpFrontPayment
63000000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
16667000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
16667000 USD
cnmd Paymentsfor Contingent Consideration Relatedto Business Acquisition
PaymentsforContingentConsiderationRelatedtoBusinessAcquisition
0 USD
cnmd Paymentsfor Contingent Consideration Relatedto Business Acquisition
PaymentsforContingentConsiderationRelatedtoBusinessAcquisition
2423000 USD
CY2015Q3 cnmd Product Liability Contingency Insurance Aggregate Annual Amount
ProductLiabilityContingencyInsuranceAggregateAnnualAmount
25000000 USD
CY2015Q3 cnmd Product Liability Contingency Insurance Amount Per Incident
ProductLiabilityContingencyInsuranceAmountPerIncident
25000000 USD
cnmd Product Warranty Accrual Term
ProductWarrantyAccrualTerm
P1Y
CY2015Q3 cnmd Restructuringand Related Activities Completion Period
RestructuringandRelatedActivitiesCompletionPeriod
P3M
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000816956
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27704856 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CONMED CORP
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23752000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
31588000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
129287000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124697000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2668000 USD
CY2015Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2157000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39822000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53812000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P27Y
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
319752000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
319710000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
19318000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
18389000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3300000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9800000 USD
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3100000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9500000 USD
CY2014Q4 us-gaap Assets
Assets
1098194000 USD
CY2015Q3 us-gaap Assets
Assets
1094047000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
381150000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
383694000 USD
CY2014Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
300000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
400000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54443000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64614000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66332000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65326000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10171000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1006000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4173000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17001000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3741000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8656000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
78547000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
245028000 USD
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
75638000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
248825000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1121000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4159000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
14348000 USD
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
12968000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1398000 USD
CY2015Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1134000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
112223000 USD
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
115398000 USD
CY2014Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-410000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-1230000 USD
CY2015Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-808000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-2425000 USD
CY2014Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1496000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
4489000 USD
CY2015Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1424000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
4273000 USD
CY2014Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
866000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2599000 USD
CY2015Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
849000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2546000 USD
CY2014Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-152000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-457000 USD
CY2015Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
293000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
878000 USD
CY2014Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
68000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
203000 USD
CY2015Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
60000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
180000 USD
us-gaap Depreciation
Depreciation
14702000 USD
us-gaap Depreciation
Depreciation
13919000 USD
CY2014Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
1032000 USD
CY2015Q3 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
1279000 USD
CY2014Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
5179000 USD
CY2015Q3 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
3638000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
6211000 USD
CY2015Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
4917000 USD
CY2014Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5504000 USD
CY2015Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5540000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3257000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-6889000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.330
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.329
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36446000 USD
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28822000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
119070000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
128182000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12877000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2936000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
13186000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13279000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
13279000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
13309000 USD
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-500000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-300000 USD
CY2015Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-800000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1100000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
256232000 USD
CY2015Q3 us-gaap Goodwill
Goodwill
260755000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
5369000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-525000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-321000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
96414000 USD
us-gaap Gross Profit
GrossProfit
300024000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
93546000 USD
us-gaap Gross Profit
GrossProfit
279326000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
909000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
31125000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13334000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
33755000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1063000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10272000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4461000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11109000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1812000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7992000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13699000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-310000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2507000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7040000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
891000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-152000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30023000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25129000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-18676000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-16074000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-375000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2431000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6161000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4366000 USD
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
435510000 USD
CY2015Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
436241000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316440000 USD
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
308059000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
1540000 USD
us-gaap Interest Expense
InterestExpense
4572000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
1504000 USD
us-gaap Interest Expense
InterestExpense
4453000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
89426000 USD
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
98573000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
148149000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
161555000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
44847000 USD
CY2015Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
46893000 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13876000 USD
CY2015Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16089000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
516896000 USD
CY2015Q3 us-gaap Liabilities
Liabilities
516622000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1098194000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1094047000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
115956000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
111656000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1234000 USD
CY2015Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1285000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
240201000 USD
CY2015Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
260545000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12606000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15255000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13495000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17582000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39529000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38720000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
1972000 USD
us-gaap Net Income Loss
NetIncomeLoss
20853000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
8873000 USD
us-gaap Net Income Loss
NetIncomeLoss
22646000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
93965000 USD
us-gaap Operating Expenses
OperatingExpenses
264327000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
78708000 USD
us-gaap Operating Expenses
OperatingExpenses
241118000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2449000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
35697000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
14838000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
38208000 USD
CY2014Q4 us-gaap Other Assets
OtherAssets
9545000 USD
CY2015Q3 us-gaap Other Assets
OtherAssets
9688000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
3566000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
3763000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-361000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-956000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
2090000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
2205000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-212000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-560000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9948000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8391000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5281000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14563000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-237000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-776000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-510000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1529000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
138000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
454000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
298000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
896000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
51856000 USD
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
47804000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
48516000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29023000 USD
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23034000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19148000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
33000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16862000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
7516000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1410000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
16455000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
16565000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
6100000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1245000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6104000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12250000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11478000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
21000000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1716000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
664000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3220000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
751000 USD
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2422000 USD
CY2014Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2341000 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2286000 USD
CY2015Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2454000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2703000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2682000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2622000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2850000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
133429000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
130717000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
558000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
605000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6910000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20674000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6652000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20695000 USD
us-gaap Restructuring Charges
RestructuringCharges
4449000 USD
CY2014Q4 us-gaap Restructuring Reserve
RestructuringReserve
8254000 USD
CY2015Q3 us-gaap Restructuring Reserve
RestructuringReserve
5187000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
406145000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
412196000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
174961000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
545052000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
169184000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
528151000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87055000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
243653000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72056000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
220423000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7691000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5561000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
581298000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
577425000 USD
CY2014Q4 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
3744473 shares
CY2015Q3 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
3598089 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
105090000 USD
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
100982000 USD
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
234000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
423000 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
197000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
217000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27688000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27777000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27898000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27853000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27454000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27354000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27701000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27636000 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.&#160;&#160;The Company&#8217;s products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.</font></div></div>

Files In Submission

Name View Source Status
0000816956-15-000010-index-headers.html Edgar Link pending
0000816956-15-000010-index.html Edgar Link pending
0000816956-15-000010.txt Edgar Link pending
0000816956-15-000010-xbrl.zip Edgar Link pending
cnmd-20150930.xml Edgar Link completed
cnmd-20150930.xsd Edgar Link pending
cnmd-20150930_cal.xml Edgar Link unprocessable
cnmd-20150930_def.xml Edgar Link unprocessable
cnmd-20150930_lab.xml Edgar Link unprocessable
cnmd-20150930_pre.xml Edgar Link unprocessable
cnmd9301510-q.htm Edgar Link pending
cnmd93015ex311.htm Edgar Link pending
cnmd93015ex312.htm Edgar Link pending
cnmd93015ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending